Interplay of adaptive Th2 immunity with eotaxin-3/C-C chemokine receptor 3 in eosinophilic esophagitis

Journal of Pediatric Gastroenterology and Nutrition

Volumn 45, Issue 1, 2007, Pages 22-31

  Bullock, Jennifer Z ^a   Villanueva, Joyce M ^a   Blanchard, Carine ^a   Filipovich, Alexandra H ^a   Putnam, Philip E ^a   Collins, Margaret H ^a   Risma, Kimberly A ^a   Akers, Rachel M ^a,b   Kirby, Cassie L ^a   Buckmeier, Bridget K ^a   Assa'ad, Amal H ^a   Hogan, Simon P ^a   Rothenberg, Marc E ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

CC chemokine receptor 3; Eosinophilic esophagitis; Eosinophils; Eotaxin 3

Indexed keywords

CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR 3; EOTAXIN; EOTAXIN 3; GAMMA INTERFERON; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 5 RECEPTOR; INTERLEUKIN 5 RECEPTOR ALPHA; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ADOLESCENT; ARTICLE; ATOPY; BLOOD SAMPLING; CD4+ T LYMPHOCYTE; CELL COUNT; CELLULAR IMMUNITY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; EOSINOPHIL; EOSINOPHILIC ESOPHAGITIS; ESOPHAGUS BIOPSY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; LYMPHOCYTE; MALE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REMISSION; TH2 CELL;

ANTIGENS, SURFACE; CHEMOKINES, CC; CHILD; CYTOKINES; EOSINOPHILIA; EOSINOPHILS; ESOPHAGITIS; HUMANS; HYPERSENSITIVITY, IMMEDIATE; IMMUNITY, CELLULAR; RECEPTORS, CHEMOKINE; RNA, MESSENGER; TH2 CELLS;

EID: 34347342792     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPG.0b013e318043c097     Document Type: Article

References (46)

1. Orenstein SR, Shalaby TM, Di Lorenzo C, et al. The spectrum of pediatric eosinophilic esophagitis beyond infancy: a clinical series of 30 children. Am J Gastroenterol 2000;95:1422-30.
2. Fox VL, Nurko S, Furuta GT. Eosinophilic esophagitis: it's not just kid's stuff. Gastrointest Endosc 2002;56:260-70.
3. Straumann A, Spichtin HP, Grize L, et al. Natural history of primary eosinophilic esophagitis: a follow-up of 30 adult patients for up to 11.5 years. Gastroenterology 2003;125:1660-9.
4. Rothenberg ME. Eosinophilic gastrointestinal disorders (EGID). J Allergy Clin Immunol 2004;113:11-28.
5. Noel RJ, Putnam PE, Rothenberg ME. Eosinophilic esophagitis. N Engl J Med 2004;351:940-1.
6. Rothenberg ME, Mishra A, Collins MH, et al. Pathogenesis and clinical features of eosinophilic esophagitis. J Allergy Clin Immunol 2001;108:891-4.
7. Spergel JM, Beausoleil JL, Mascarenhas M, et al. The use of skin prick tests and patch tests to identify causative foods in eosinophilic esophagitis. J Allergy Clin Immunol 2002;109:363-8.
8. Walsh SV, Antonioli DA, Goldman H, et al. Allergic esophagitis in children: a clinicopathological entity. Am J Surg Pathol 1999;23:390-6.
9. Scudamore HH, Phillips SF, Swedlund HA, et al. Food allergy manifested by eosinophilia, elevated immunoglobulin E level, and protein-losing enteropathy: the syndrome of allergic gastroenteropathy. J Allergy Clin Immunol 1982;70:129-36.
10. Kelly KJ, Lazenby AJ, Rowe PC, et al. Eosinophilic esophagitis attributed to gastroesophageal reflux: improvement with an amino acid-based formula. Gastroenterology 1995;109:1503-12.
11. Markowitz JE, Liacouras CA. Eosinophilic esophagitis. Gastroenterol Clin North Am 2003;32:949-66.
12. Straumann A, Bauer M, Fischer B, et al. Idiopathic eosinophilic esophagitis is associated with a TH2-type allergic inflammatory response. J Allergy Clin Immunol 2001;108:954-61.
13. Teitelbaum JE, Fox VL, Twarog FJ, et al. Eosinophilic esophagitis in children: immunopathological analysis and response to fluticasome propionate. Gastoenterology 2002;122:1216-25.
14. Noel RJ, Putnam PE, Collins MH, et al. Clinical and immunopathologic effects of swallowed fluticasone for eosinophilic esophagitis. Clin Gastroenterol Hepatol 2004;2:568-75.
15. Gupta SK, Fitzgerald JF, Kondratyuk T, et al. Cytokine expression in normal and inflamed esophageal mucosa: a study into the pathogenesis of allergic eosinophilic esophagitis. J Pediatr Gastroenterol Nutr 2006;42:22-6.
16. Rothenberg ME, Hogan SP. The eosinophil. Annu Rev Immunol 2006;24:147-74.
17. Mishra A, Hogan SP, Brandt EB, et al. Interleukin-5 promotes eosinophil trafficking to the esophagus. J Immunol 2002;168:2464-9.
18. Mishra A, Hogan SP, Lee JJ, et al. Fundamental signals that regulate eosinophil homing to the gastrointestinal tract. J Clin Invest 1999;103:1719-27.
19. Mishra A, Hogan SP, Brandt EB, et al. An etiological role for aeroallergens and eosinophils in experimental esophagitis. J Clin Invest 2001;107:83-90.
20. Akei HS, Mishra A, Blanchard C, et al. Epicutaneous antigen exposure primes for experimental eosinophilic esophagitis in mice. Gastroenterology 2005;129:985-94.
21. Blanchard C, Wang N, Stringer KF, et al. Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis. J Clin Invest 2006;116:536-47.
22. Mishra A, Rothenberg ME. Intratracheal IL-13 induces eosinophilic esophagitis by an IL-5, eotaxin-1, and STAT6-dependent mechanism. Gastroenterology 2003;125:1419-27.
23. Teran LM, Mochizuki M, Bartels J, et al. Th1- and Th2-type cytokines regulate the expression and production of eotaxin and RANTES by human lung fibroblasts. Am J Respir Cell Mol Biol 1999;20:777-86.
24. van Wetering S, Zuyderduyn S, Ninaber DK, et al. Epithelial differentiation is a determinant in the production of eotaxin-2 and -3 by bronchial epithelial cells in response to IL-4 and IL-13. Mol Immunol 2007;44:802-11.
25. Kagami S, Saeki H, Komine M, et al. Interleukin-4 and interleukin-13 enhance CCL26 production in a human keratinocyte cell line, HaCaT cells. Clin Exp Immunol 2005;141:459-66.
26. Rothenberg ME. Eosinophilia. N Engl J Med 1998;338:1592-600.
27. Zimmermann N, Conkright JJ, Rothenberg ME. CC chemokine receptor-3 undergoes prolonged ligand-induced internalization. J Biol Chem 1999;274:12611-8.
28. Petersen CM, Christensen EI, Andersen DS, et al. Internalization, lysosomal degradation and new synthesis of surface membrane CD4 in phorbol ester-activated T-lymphocytes and U-937 cells. Exp Cell Res 1992;201:160-73.
29. Moller BK, Andersen BS, Christensen EI, et al. Surface membrane CD4 turnover in phorbol ester stimulated T-lymphocytes: evidence of degradation and increased synthesis. FEBS Lett 1990;276:59-62.
30. Solbach W. Tumor-promoting phorbol esters selectively abrogate the expression of the T4 differentiation antigen expressed on normal and malignant (Sezary) T helper lymphocytes. J Exp Med 1982;156:1250-5.
31. Garrett JK, Jameson SC, Thomson B, et al. Anti-interleukin-5 (mepolizumab) therapy for hypereosinophilic syndromes. J Allergy Clin Immunol 2004;113:115-9.
32. Gleich GJ. Mechanisms of eosinophil-associated inflammation. J Allergy Clin Immunol 2000;105:651-63.
33. Lamkhioued B, Abdelilah S, Hamid Q, et al. The CCR3 receptor is involved in eosinophil differentiation and is up-regulated by Th2 cytokines in CD34+ progenitor cells. J Immunol 2002;169:537-47.
34. Sehmi R, Dorman S, Baatjes A, et al. Allergen-induced fluctuation in CC chemokine receptor 3 expression on bone marrow CD34+ cells from asthmatic subjects: significance for mobilization of haemopoietic progenitor cells in allergic inflammation. Immunology 2003;109:536-46.
35. Simson L, Foster PS. Chemokine and cytokine cooperativity: eosinophil migration in the asthmatic response. Immunol Cell Biol 2000;78:415-22.
36. Pope SM, Zimmermann N, Stringer KF, et al. The eotaxin chemokines and CCR3 are fundamental regulators of allergen-induced pulmonary eosinophilia. J Immunol 2005;175:5341-50.
37. Palframan RT, Collins PD, Williams TJ, et al. Eotaxin induces a rapid release of eosinophils and their progenitors from the bone marrow. Blood 1998;91:2240-8.
38. Nagase H, Kudo K, Izumi S, et al. Chemokine receptor expression profile of eosinophils at inflamed tissue sites: decreased CCR3 and increased CXCR4 expression by lung eosinophils. J Allergy Clin Immunol 2001;108:563-9.
39. Liu L, Jarjour NN, Busse WW, et al. Chemokine receptor expression on human eosinophils from peripheral blood and bronchoalveolar lavage fluid after segmental allergen challenge. J Allergy Clin Immunol 2003;112:556-62.
40. Kimura M, Nakayama T. Differentiation of NK1 and NK2 cells. Crit Rev Immunol 2005;25:361-74.
41. Wei H, Zhang J, Xiao W, et al. Involvement of human natural killer cells in asthma pathogenesis: natural killer 2 cells in type 2 cytokine predominance. J Allergy Clin Immunol 2005;115:841-7.
42. Meresse B, Curran SA, Ciszewski C, et al. Reprogramming of CTLs into natural killer-like cells in celiac disease. J Exp Med 2006;203:1343-55.
43. Fogg MI, Ruchelli E, Spergel JM. Pollen and eosinophilic esophagitis. J Allergy Clin Immunol 2003;112:796-7.
44. Weller P. Eosinophilia and eosinophil-related disorders. In: Adkinson Jr NF, Yunginger JW, Busse WW (eds) et al. Middleton's Allergy: Principles and Practice. Philadelphia: CV Mosby; 2003; pp. 1105-25.
45. Onbasi K, Sin AZ, Doganavsargil B, et al. Eosinophil infiltration of the oesophageal mucosa in patients with pollen allergy during the season. Clin Exp Allergy 2005;35:1423-31.
46. Ronkainen J, Talley NJ, Aro P, et al. Prevalence of oesophageal eosinophils and eosinophilic oesophagitis in adults: the population-based Kalixanda study. Gut 2006;29:29.